drugset / Trial / NCT05694637
Botswana Smoking and Abstinence Reinforcement Trial
Phase 4
Enrolling by invitation
750 enrolled
University of Maryland, Baltimore
University of Chicago · collabUniversity of Maryland, Baltimore County · collabUniversity of Maryland, College Park · collab
RandomizedCrossoverOpen-labelPrevention
Summary
Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.
Timeline
- Start
- 2023-07-25
- Primary completion
- 2027-02-01
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varenicline | Small molecule | — | — |